Erika Carmel-Tech Ltd Total Liabilities

Latest as of June 2026: ILA21.86 Million ILA ≈ $58.61K USD

Erika Carmel-Tech Ltd total liabilities. Based on the latest financial reports, Erika Carmel-Tech Ltd (ERKA) has total liabilities worth ILA21.86 Million ILA (≈ $58.61K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Erika Carmel-Tech Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Erika Carmel-Tech Ltd (2019–2025)

Total liabilities of Erika Carmel-Tech Ltd from 2019 to 2025. This chart illustrates how Erika Carmel-Tech Ltd's total liabilities have evolved over time, based on quarterly financial data.

Erika Carmel-Tech Ltd Competitors by Total Liabilities

The table below lists competitors of Erika Carmel-Tech Ltd ranked by their total liabilities.

Company Country Total Liabilities
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
USA $5.54 Million
Eka Sari Lorena Transport Tbk
JK:LRNA
Indonesia Rp35.11 Billion
Borneo Olah Sarana Sukses PT
JK:BOSS
Indonesia Rp797.31 Billion
Geotrans SA
WAR:GTS
Poland zł5.92 Million
Impera Capital S.A.
WAR:IMP
Poland zł702.00K
Sfinks Polska S.A.
WAR:SFS
Poland zł142.84 Million
Reliance Global Group Inc
NASDAQ:RELI
USA $6.37 Million
LOBO EV TECHNOLOGIES LTD. Ordinary shares
NASDAQ:LOBO
USA $13.53 Million

Liability Composition Analysis (2019–2025)

This chart breaks down Erika Carmel-Tech Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Erika Carmel-Tech Ltd balance sheet assets.

Liquidity & Leverage Metrics

Erika Carmel-Tech Ltd Total Liabilities Ratios Explained

Erika Carmel-Tech Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.71 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.82 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Erika Carmel-Tech Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Erika Carmel-Tech Ltd (2019–2025)

The table below shows the annual total liabilities of Erika Carmel-Tech Ltd from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 ILA19.37 Million
≈ $51.93K
-1.74%
2024-12-31 ILA19.71 Million
≈ $52.84K
-14.97%
2023-12-31 ILA23.18 Million
≈ $62.14K
-9.87%
2022-12-31 ILA25.72 Million
≈ $68.95K
-30.62%
2021-12-31 ILA37.07 Million
≈ $99.38K
-4.31%
2020-12-31 ILA38.74 Million
≈ $103.86K
+68.76%
2019-12-31 ILA22.95 Million
≈ $61.54K
--

About Erika Carmel-Tech Ltd

TA:ERKA Israel Medical Devices
Market Cap
$4.10 Million
ILA1.53 Billion ILA
Market Cap Rank
#28882 Global
#414 in Israel
Share Price
ILA36.70
Change (1 day)
-4.92%
52-Week Range
ILA18.00 - ILA55.20
All Time High
ILA55.20
About

Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. T… Read more